Global Cardiopulmonary Autotransfusion Systems Market Research Report 2024(Status and Outlook)

Global Cardiopulmonary Autotransfusion Systems Market Research Report 2024(Status and Outlook)



Report Overview: Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss. The Global Cardiopulmonary Autotransfusion Systems Market Size was estimated at USD 569.49 million in 2023 and is projected to reach USD 656.58 million by 2029, exhibiting a CAGR of 2.40% during the forecast period. This report provides a deep insight into the global Cardiopulmonary Autotransfusion Systems market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cardiopulmonary Autotransfusion Systems Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cardiopulmonary Autotransfusion Systems market in any manner. Global Cardiopulmonary Autotransfusion Systems Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Company Advancis Surgical Fresenius Kabi Haemonetics LivaNova Medtronic Terumo Atrium Medical Global Blood Resources Redax Sarstedt Stryker Market Segmentation (by Type) Unwashed ATS Washed ATS Market Segmentation (by Application) Heart Surgery Great Organ Transplant Surgery Others Geographic Segmentation • North America (USA, Canada, Mexico) • Europe (Germany, UK, France, Russia, Italy, Rest of Europe) • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) • South America (Brazil, Argentina, Columbia, Rest of South America) • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA) Key Benefits of This Market Research: • Industry drivers, restraints, and opportunities covered in the study • Neutral perspective on the market performance • Recent industry trends and developments • Competitive landscape & strategies of key players • Potential & niche segments and regions exhibiting promising growth covered • Historical, current, and projected market size, in terms of value • In-depth analysis of the Cardiopulmonary Autotransfusion Systems Market • Overview of the regional outlook of the Cardiopulmonary Autotransfusion Systems Market: Key Reasons to Buy this Report: • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change • This enables you to anticipate market changes to remain ahead of your competitors • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly • Provision of market value (USD Billion) data for each segment and sub-segment • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis • Provides insight into the market through Value Chain • Market dynamics scenario, along with growth opportunities of the market in the years to come • 6-month post-sales analyst support Customization of the Report In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met. Note: this report may need to undergo a final check or review and this could take about 48 hours. Chapter Outline Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods. Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cardiopulmonary Autotransfusion Systems Market and its likely evolution in the short to mid-term, and long term. Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market. Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis. Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc. Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years. Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years. Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cardiopulmonary Autotransfusion Systems
1.2 Key Market Segments
1.2.1 Cardiopulmonary Autotransfusion Systems Segment by Type
1.2.2 Cardiopulmonary Autotransfusion Systems Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cardiopulmonary Autotransfusion Systems Market Overview
2.1 Global Market Overview
2.1.1 Global Cardiopulmonary Autotransfusion Systems Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cardiopulmonary Autotransfusion Systems Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cardiopulmonary Autotransfusion Systems Market Competitive Landscape
3.1 Global Cardiopulmonary Autotransfusion Systems Sales by Manufacturers (2019-2024)
3.2 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Manufacturers (2019-2024)
3.3 Cardiopulmonary Autotransfusion Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cardiopulmonary Autotransfusion Systems Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cardiopulmonary Autotransfusion Systems Sales Sites, Area Served, Product Type
3.6 Cardiopulmonary Autotransfusion Systems Market Competitive Situation and Trends
3.6.1 Cardiopulmonary Autotransfusion Systems Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cardiopulmonary Autotransfusion Systems Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cardiopulmonary Autotransfusion Systems Industry Chain Analysis
4.1 Cardiopulmonary Autotransfusion Systems Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cardiopulmonary Autotransfusion Systems Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cardiopulmonary Autotransfusion Systems Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Type (2019-2024)
6.3 Global Cardiopulmonary Autotransfusion Systems Market Size Market Share by Type (2019-2024)
6.4 Global Cardiopulmonary Autotransfusion Systems Price by Type (2019-2024)
7 Cardiopulmonary Autotransfusion Systems Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cardiopulmonary Autotransfusion Systems Market Sales by Application (2019-2024)
7.3 Global Cardiopulmonary Autotransfusion Systems Market Size (M USD) by Application (2019-2024)
7.4 Global Cardiopulmonary Autotransfusion Systems Sales Growth Rate by Application (2019-2024)
8 Cardiopulmonary Autotransfusion Systems Market Segmentation by Region
8.1 Global Cardiopulmonary Autotransfusion Systems Sales by Region
8.1.1 Global Cardiopulmonary Autotransfusion Systems Sales by Region
8.1.2 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Region
8.2 North America
8.2.1 North America Cardiopulmonary Autotransfusion Systems Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cardiopulmonary Autotransfusion Systems Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cardiopulmonary Autotransfusion Systems Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cardiopulmonary Autotransfusion Systems Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Advancis Surgical
9.1.1 Advancis Surgical Cardiopulmonary Autotransfusion Systems Basic Information
9.1.2 Advancis Surgical Cardiopulmonary Autotransfusion Systems Product Overview
9.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Product Market Performance
9.1.4 Advancis Surgical Business Overview
9.1.5 Advancis Surgical Cardiopulmonary Autotransfusion Systems SWOT Analysis
9.1.6 Advancis Surgical Recent Developments
9.2 Fresenius Kabi
9.2.1 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Basic Information
9.2.2 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product Overview
9.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product Market Performance
9.2.4 Fresenius Kabi Business Overview
9.2.5 Fresenius Kabi Cardiopulmonary Autotransfusion Systems SWOT Analysis
9.2.6 Fresenius Kabi Recent Developments
9.3 Haemonetics
9.3.1 Haemonetics Cardiopulmonary Autotransfusion Systems Basic Information
9.3.2 Haemonetics Cardiopulmonary Autotransfusion Systems Product Overview
9.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Product Market Performance
9.3.4 Haemonetics Cardiopulmonary Autotransfusion Systems SWOT Analysis
9.3.5 Haemonetics Business Overview
9.3.6 Haemonetics Recent Developments
9.4 LivaNova
9.4.1 LivaNova Cardiopulmonary Autotransfusion Systems Basic Information
9.4.2 LivaNova Cardiopulmonary Autotransfusion Systems Product Overview
9.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Product Market Performance
9.4.4 LivaNova Business Overview
9.4.5 LivaNova Recent Developments
9.5 Medtronic
9.5.1 Medtronic Cardiopulmonary Autotransfusion Systems Basic Information
9.5.2 Medtronic Cardiopulmonary Autotransfusion Systems Product Overview
9.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Product Market Performance
9.5.4 Medtronic Business Overview
9.5.5 Medtronic Recent Developments
9.6 Terumo
9.6.1 Terumo Cardiopulmonary Autotransfusion Systems Basic Information
9.6.2 Terumo Cardiopulmonary Autotransfusion Systems Product Overview
9.6.3 Terumo Cardiopulmonary Autotransfusion Systems Product Market Performance
9.6.4 Terumo Business Overview
9.6.5 Terumo Recent Developments
9.7 Atrium Medical
9.7.1 Atrium Medical Cardiopulmonary Autotransfusion Systems Basic Information
9.7.2 Atrium Medical Cardiopulmonary Autotransfusion Systems Product Overview
9.7.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Product Market Performance
9.7.4 Atrium Medical Business Overview
9.7.5 Atrium Medical Recent Developments
9.8 Global Blood Resources
9.8.1 Global Blood Resources Cardiopulmonary Autotransfusion Systems Basic Information
9.8.2 Global Blood Resources Cardiopulmonary Autotransfusion Systems Product Overview
9.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Product Market Performance
9.8.4 Global Blood Resources Business Overview
9.8.5 Global Blood Resources Recent Developments
9.9 Redax
9.9.1 Redax Cardiopulmonary Autotransfusion Systems Basic Information
9.9.2 Redax Cardiopulmonary Autotransfusion Systems Product Overview
9.9.3 Redax Cardiopulmonary Autotransfusion Systems Product Market Performance
9.9.4 Redax Business Overview
9.9.5 Redax Recent Developments
9.10 Sarstedt
9.10.1 Sarstedt Cardiopulmonary Autotransfusion Systems Basic Information
9.10.2 Sarstedt Cardiopulmonary Autotransfusion Systems Product Overview
9.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Product Market Performance
9.10.4 Sarstedt Business Overview
9.10.5 Sarstedt Recent Developments
9.11 Stryker
9.11.1 Stryker Cardiopulmonary Autotransfusion Systems Basic Information
9.11.2 Stryker Cardiopulmonary Autotransfusion Systems Product Overview
9.11.3 Stryker Cardiopulmonary Autotransfusion Systems Product Market Performance
9.11.4 Stryker Business Overview
9.11.5 Stryker Recent Developments
10 Cardiopulmonary Autotransfusion Systems Market Forecast by Region
10.1 Global Cardiopulmonary Autotransfusion Systems Market Size Forecast
10.2 Global Cardiopulmonary Autotransfusion Systems Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cardiopulmonary Autotransfusion Systems Market Size Forecast by Country
10.2.3 Asia Pacific Cardiopulmonary Autotransfusion Systems Market Size Forecast by Region
10.2.4 South America Cardiopulmonary Autotransfusion Systems Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cardiopulmonary Autotransfusion Systems by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cardiopulmonary Autotransfusion Systems Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cardiopulmonary Autotransfusion Systems by Type (2025-2030)
11.1.2 Global Cardiopulmonary Autotransfusion Systems Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cardiopulmonary Autotransfusion Systems by Type (2025-2030)
11.2 Global Cardiopulmonary Autotransfusion Systems Market Forecast by Application (2025-2030)
11.2.1 Global Cardiopulmonary Autotransfusion Systems Sales (K Units) Forecast by Application
11.2.2 Global Cardiopulmonary Autotransfusion Systems Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings